Articles

Feds reject Indiana’s Medicaid plan

The federal Health and Human Services Department is telling the state of Indiana that its Medicaid plan, which bans funding to Planned Parenthood, is illegal and must be changed.

Read More

Hoosiers in line for $30M in rebates

Only 19 of the 63 companies writing individual health insurance policies in Indiana have been meeting the new 80-percent medical-loss threshold of the health care reform law, potentially triggering a refund for customers.

Read More

Brain barrier breached in push to deliver Alzheimer’s drug

Scientists with Roche Holding AG, the parent company of Indianapolis-based Roche Diagnostics Corp., may have found a way to overcome a blood barrier that keeps drugs from directly entering the brain, potentially opening new pathways to attack Alzheimer’s disease.

Read More

Q&A

Bob Brody, CEO of Franciscan St. Francis Health, which operates three hospitals in central Indiana as part of the 13-hospital Franciscan Alliance system, discussed the rationale for its decision to take control of Visiting Nurse Service Inc.

Read More

Lilly licenses Xigris rights to new biotech firm

Eli Lilly and Co. has agreed to license the U.S. marketing rights of its slow-selling sepsis drug Xigris to a newly created local biotech company called BioCritica that will seek to reinvigorate sales of the medication.

Read More

OrthoIndy looks to loopholes for growth

OrthoIndy, the physician practice that owns the Indiana Orthopaedic Hospital, was able to open a new outpatient facility this spring by working around growth restrictions in the 2010 health care reform law. But its choices for further growth are much starker—which is why it’s lobbying to repeal that provision of the law.

Read More

Health insurers lose push to ease rate review

U.S. insurers led by WellPoint Inc. and UnitedHealth Group Inc. failed to get federal regulators to change a rule in the 2010 health-care overhaul that triggers a review of any premium increases exceeding 10 percent.

Read More